Evonik Draws a Line BASF Has Yet to Cross: Information, Not Negotiation

Evonik's board has made its position plain: it will not negotiate over BASF's voluntary public takeover offer, and it intends to keep charting its own strategic course. What it will do is talk — strictly for information, and strictly in confidence. That distinction sits at the heart of the standoff, because a willingness to exchange facts is not the same as a mandate to bargain over a merger.

The refusal covers BASF's bid of EUR 24.00 per share. Even that figure — raised about a week ago and, according to Handelsblatt, worth roughly EUR 11.2 billion — failed to move the board into talks. Evonik instead reaffirmed its focus on standalone development, framing any contact with BASF within deliberately narrow bounds. Confidential dialogue can convey information; under the board's explicit positioning, it does not amount to negotiation. Nor does it signal movement on price or any fundamental acceptance of the takeover.

A Bid Above the Market, Not a Locked-In Payday

For shareholders, the offer remains a reference point rather than a secured exit value. Friday's closing price of EUR 21.06 sat below the rejected EUR 24.00 proposal. That gap is not a guaranteed return opportunity: Evonik has declared no readiness to negotiate the terms on offer, and nothing in the share price can be read as a sign of a later agreement or its likelihood.

BASF, for its part, answered Friday's decision with incomprehension, according to Reuters. The bidder pointed not only to its improved offer but also to commitments covering employees and sites. Those pledges form part of BASF's case; they do not establish Evonik's consent.

Kamieth Signals Interest — and a Ceiling

BASF chief executive Markus Kamieth reinforced the company's interest in a deal on Wednesday, telling Reuters he has no intention of paying an inflated price. He declined to comment on the status of discussions. Two positions thus sit opposite each other: Evonik is betting on independence, while BASF signals appetite and stresses financial discipline in the same breath. A further sweetened bid cannot be inferred as the assured next step — and Evonik's openness to an information exchange does not mean its stated rejection of negotiations has begun to soften.

Syneqt Adds a Second Front

How far apart the two sides' visions run emerges at Evonik subsidiary Syneqt. Its managing director spokesperson stressed on Tuesday, per Reuters, a desire for independence, after BASF had said it could envisage operating the chemical parks itself if necessary. The dispute therefore reaches into how individual business units would be structured going forward. The Syneqt comments expose divergent views on its future; they do not constitute an agreement for BASF to run the operations.

Separately, a possible transaction of Evonik's own is in the air. Reuters reported on 22 October, citing two insiders, that Evonik is examining an acquisition of US rival Ashland. Evonik has not commented. That report should not be treated as a decided alternative to the BASF offer — the reliable anchor for investors remains the declared commitment to independence.

November 3 as the Next Yardstick

Evonik has scheduled publication of its third-quarter 2026 business development for 3 November 2026, giving investors the next concrete occasion to assess the economic foundation of the standalone path. Until then, the key dividing line holds: Evonik is offering information, not takeover negotiations. Anyone valuing the stock on takeover grounds must weigh that explicitly drawn boundary alongside the offer price itself.